The efficacy and safety of bevacizumab combined with chemotherapy in treatment of HER2-negative metastatic breast cancer: a meta-analysis based on published phase III trials
Crossref DOI link: https://doi.org/10.1007/s13277-014-2799-7
Published Online: 2014-11-12
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fang, Yuan
Qu, Xinlan
Cheng, Boran
Chen, Yuanyuan
Wang, Zhenmeng
Chen, Fangfang
Xiong, Bin
Text and Data Mining valid from 2014-11-12